Author(s), (publication year) | Country of Study | Duration of study | N | Follow-up period mean ± sd (range) (yr) | M:F | Mortality rate (%) | Survival rate | Remark | ||
---|---|---|---|---|---|---|---|---|---|---|
1 year | 5 year | 10 year | ||||||||
Present study | Thailand | 1985–2016 | 331 | 7.7 ± 4.9 (1–28) | 1:5 | 24 | 93 | 82 | 72 | Pediatric Nephrology Clinic |
1985–1996 | 52 | 14.7 ± 6.9 (1–28) | 1:4 | 52 | 89 | 66 | 62 | |||
1997–2006 | 136 | 9.4 ± 3.9 (1–18) | 1:5 | 34 | 93 | 79 | 69 | |||
2007–2016 | 143 | 5.1 ± 2.5 (1–10) | 1:5 | 10 | 96 | 91 | 89 | |||
Baqi, 1996 [17] | USA | 1965–1992 | 56 | 5.3 (6 mo-20) | 1:5 | 16 | – | 44 | 29 | 64% Black, 50% ESRD |
Yang, 1994 [25] | Taiwan | 1979–1991 | 167 | 4.9 (1–13) | 1:11 | 9 | – | 91 | – | All LN, 10 ESRD |
Hagelberg, 2002 [10] | Canada | 1984–1991 | 67 | 11.0 (5–19) | 1:4 | 6 | – | 97 | 95 | All LN |
Wong, 2006 [9] | Hong Kong | 1990–2003 | 128 | 5.8 ± 3.6 (−) | 1:15 | 4 | – | 95 | 92 | 40% renal involvement |
Lee, 2013 [2] | Taiwan | 1990–2012 | 189 | 6.9 ± 4.6 (0–22) | 1:7 | 7 | – | 93 | 90a | Pediatric Rheumatology Clinic, LN 52% |
Abujam, 2016 [20] | India | 1991–2013 | 122 | 4.8 ± 4.5 (3 mo-20) | 1:3 | 20 | 88 | 78 | 71 | General Pediatric Center |
Fatami 2017 [3] | Iran | 1992–2013 | 180 | – | 1:3 | 11 | 91 | 87 | ||
Al-Mayouf, 2008 [24] | Saudi Arabia | 1995–2007 | 89 | 5.1 (−) | 1:6 | 9 | 91 | – | Most affected organ: neuropsychiatric | |
Tavangar-Rad 2014 [26] | Iran | 2004–2010 | 120 | 4.7 ± 2.7 (1–10) | 1:3 | 10 | 97 | 89 | – | Pediatric Rheumatology Clinic, LN 60% |